USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11838
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMirzac, Daniela
dc.date.accessioned2020-09-30T14:58:11Z
dc.date.available2020-09-30T14:58:11Z
dc.date.issued2016
dc.identifier.citationMIRZAC, Daniela. The role of glutathione in cancer development and chemoresistance. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, pp. 252-253.en_US
dc.identifier.isbn978-9975-3028-3-8.
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11838
dc.descriptionDepartment of Biochemistry and Clinical Biochemistry, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 6th International Medical Congress for Students and Young Doctorsen_US
dc.description.abstractIntroduction: Glutathione (GSH) is a tripeptide produced by the liver and has the ability (among others) to remove a wide range of toxins, including those produced by heavy metals, alcohol, smoking, radiation and cancer chemotherapy. Elevated GSH levels were detected in various types of tumors, along with high levels of GSH-related enzymes, such as 𝛾𝛾-glutamylcysteine ligase (GCL) and 𝛾𝛾-glutamyltranspeptidase (GGT), GSH-transporting export pumps. This makes the neoplastic tissues more resistant to chemotherapy. Therefore, the GSH system attracted the attention of scientists as a possible target for medical intervention against cancer progression and chemoresistance. Materials and methods: The presentation represents an extensive literature review and is based on relevant scientific articles regarding the subject from medical databases. Discussion results: The main research in the field aimed at depleting GSH by a specific inhibition of GCL, a key enzyme of GSH biosynthesis. But GSH depletion appears to be therapeutically effective when very low levels (<10% of their control values) can be achieved within the cancer cells. Thus, achievement of selective tumor GSH depletion under in vivo circumstances is a pharmacological challenge. Also, GSH synthesis and GSH synthesis-linked genes are up-regulated during oxidative stress and inflammation. Furthermore, Nrf-2 deficient cells were more susceptible to doxorubicin and BSO treatment-induced cell death than wild cells. Moreover, propyl gallate activated caspases 3, 8, and 9, and induced an increase in p53, Bax, Fas, and Fas Ligand; whereas MAPKs inhibited nuclear translocation of Nrf-2 and induced intracellular GSH depletion in human leukemia. This indicates that Nrf-2 is one of the first factors that induce cell survival under GSH depletion, which points out to this transcription factor as an attractive target in leukemia but also in other cancers sharing similar molecular mechanisms. The increase in GSH is a major contributing factor to drug resistance by binding to or reacting with, drugs, interacting with ROS, preventing damage to proteins or DNA, or by participating in DNA repair processes. Conclusion: The modulation of cellular GSH is a double-edged sword. On one hand, enhancing the capacity of GSH and its Associated enzymes represents an aim in the search for cytoprotective strategies against cancer. On the other hand, the strategy of depleting GSH and GSH-related detoxification pathways is aimed at sensitizing cancer cells to chemotherapy.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectGlutathioneen_US
dc.subjectcancer developmenten_US
dc.subjectchemoresistanceen_US
dc.titleThe role of glutathione in cancer development and chemoresistanceen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2016

Files in This Item:
File Description SizeFormat 
The_role_of_glutathione_in_cancer_development_and_chemoresistance.pdf275.01 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback